Wld S protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice
Authors:
Open Access
- 8 July 2011
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 54 (9) , 2440-2450
Abstract
We aimed to evaluate the effect of the mutant Wld S (slow Wallerian degeneration; also known as Wld) gene in experimental diabetes on early experimental peripheral diabetic neuropathy and diabetic retinopathy.Keywords
This publication has 44 references indexed in Scilit:
- New Therapeutic and Biomarker Discovery for Peripheral Diabetic Neuropathy: PARP Inhibitor, Nitrotyrosine, and Tumor Necrosis Factor-αEndocrinology, 2010
- Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetesDiabetologia, 2010
- Caloric restriction, SIRT1 and longevityTrends in Endocrinology & Metabolism, 2009
- Retinal ganglion cells in diabetesThe Journal of Physiology, 2008
- Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human DiseaseThe American Journal of Pathology, 2008
- PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathyFree Radical Biology and Medicine, 2008
- Age‐associated loss of Sirt1‐mediated enhancement of glucose‐stimulated insulin secretion in beta cell‐specific Sirt1‐overexpressing (BESTO) miceAging Cell, 2007
- Poly(ADP-ribose) (PAR) polymer is a death signalProceedings of the National Academy of Sciences, 2006
- Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β CellsPLOS Biology, 2005
- Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axonJournal of Neurocytology, 1993